SEC Form 4 · accession 0000920465-15-000042
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
May 12, 2015
Accepted (ET)
May 13, 2015 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2015 | P | 2,000 | $18.38 | A | 22,000 | I | By children |
| Common StockF2 | May 12, 2015 | P | 2,000 | $18.36 | A | 1,423,086 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted-average price at which shares were purchased within a range between $18.25 and $18.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2Represents the weighted-average price at which shares were purchased within a range between $18.22 and $18.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.